T-Cell Prolymphocytic Leukemia Clinical Trials

21 clinical trials for T-Cell Prolymphocytic Leukemia across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia — RECRUITING · PHASE1
• Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) — RECRUITING · PHASE1
• A Registry for People With T-cell Lymphoma — RECRUITING
• Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. — RECRUITING · PHASE1
• Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma — RECRUITING · PHASE2
• A Study of Ruxolitinib and Duvelisib in People With Lymphoma — RECRUITING · PHASE1
• Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells — RECRUITING · PHASE1
• Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies — SUSPENDED · PHASE1
• Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients — ACTIVE_NOT_RECRUITING · PHASE1
• Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors — COMPLETED · PHASE1
• Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab — COMPLETED · PHASE2
• Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia — COMPLETED · PHASE1
• A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia — COMPLETED · PHASE2
• Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) — COMPLETED · PHASE1
• Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) — COMPLETED · PHASE2
• Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma — COMPLETED · PHASE1
• Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant — COMPLETED · PHASE2
• Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia — COMPLETED · PHASE2
• Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia — COMPLETED · PHASE2
• CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma — OTHER · PHASE1
• A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) — COMPLETED · PHASE1

Refine this search